DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Avitriptan
Avitriptan
Download
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(12) Patent Application Publication (10) Pub. No.: US 2015/0202317 A1 Rau Et Al
Lääkeaineiden Yleisnimet (INN-Nimet) 21.6.2021
Abortive Antimigraine Medication 123 Absenteeism 25, 29
WO 2018/152334 Al 23 August 2018 (23.08.2018) W !P O PCT
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
A Phase 3 Open-Label, Multicenter, Randomized Study of ASP2215
An Efficient Fischer Indole Synthesis of Avitriptan, a Potent 5-HT1D Receptor Agonist
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
RPCN Content
(12) Patent Application Publication (10) Pub. No.: US 2004/0058896 A1 Dietrich Et Al
Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Triptans, 5-HT1B/1D Receptor Agonists in the Acute Treatment of Migraines
Effects of Avitriptan, a New 5-HT1B/1D Receptor Agonist, in Experimental Models Predictive of Antimigraine Activity and Coronary Side-Effect Potential
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Top View
Customs Tariff - Schedule
Lasmiditan Mechanism of Action – Review of a Selective 5-HT1F Agonist David B
Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds S
Pharmaabkommen A1 E
Antimigraine Drug Avitriptan Is a Ligand and Agonist of Human Aryl Hydrocarbon Receptor That Induces CYP1A1 in Hepatic and Intestinal Cells
Customs Tariff - Schedule Xxi - 1
WO 2013/156035 Al 24 October 2013 (24.10.2013) P O P C T
Success and Failure of Triptans Peer Tfelt-Hansen
Pharmaceutical Appendix to the Tariff Schedule 2
(12) Patent Application Publication (10) Pub. No.: US 2005/0065094A1 Davidai (43) Pub
Annexe I - Substances Pharmaceutiques, Admises En Exonération Des Droits______
Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
(12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
Harmonized Tariff Schedule of the United States (2006) (Rev
Non-Interventional PASS Protocol
© 2016 Marlene T. Kim ALL RIGHTS RESERVED
Migraine Headaches
(12) United States Patent (10) Patent No.: US 8,618,148 B2 Davidai (45) Date of Patent: Dec
WO 2017/130141 Al 3 August 2017 (03.08.2017) P O P C T
Tepzz 5 58¥Zb T
Customs Tariff - Schedule
Pharmaceutical Appendix to the Tariff Schedule 2
5-Hydroxytryptamine Receptors Mediating Carotid and Systemic Haemodynamic Effects: the Relation to Acute Antimigraine Therapy ISBN 90-9013051-9 NUGI 741/746
Drug Class Review on Triptans
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
NCT02014558 Date of Protocol Version 12.0: 02 June 2017
3 Flurbiprofen
WO 2017/063771 Al 20 April 2017 (20.04.2017) P O P C T
WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
Schedule Clxxiii - European Union